All In MedTech

Device Trial Radar · NCT04388332

ACDF Using Structural Allograft vs. Tritanium C

Comparison of Clinical Outcomes Following ACDF With Instrumentation Using Structural Allograft vs. Tritanium C

Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Aug 20, 2020

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
VB Spine, LLC
First posted
May 14, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an observational, descriptive, prospective and retrospective data collection study. The purpose of this study is to observe radiographic outcomes of patients who will undergo anterior cervical discectomy and fusion (ACDF) utilizing Tritanium C (Stryker Spine). The rate of fusion success and adverse events will be compared retrospectively to patients who underwent instrumented ACDF utilizing structural allograft bone with plates.

Conditions

  • Degenerative Disc Disease

Interventions

  • Structural allograftProcedure

    Subjects that have received ACDF structural allograft with plates with autograft and/or allograft comprised of cancellous and/or corticocancellous bone chips

  • Tritanium CDevice

    Subjects will receive the Tritanium C anterior cervical cage which is intended to be used with autogenous or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to the presence of fusionTime frame: 3 months post-operatively
  2. Time to the presence of fusionTime frame: 6 months post-operatively
  3. Time to the presence of fusionTime frame: 12 months post-operatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Allegheny Health Network

    Pittsburgh, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.